Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Handling of Rejected Vials

Posted on By

SOP for Handling of Rejected Vials

Standard Operating Procedure for Handling of Rejected Vials

1) Purpose

The purpose of this SOP is to define the procedures for handling and disposing of rejected vials to prevent contamination and ensure regulatory compliance.

2) Scope

This SOP applies to all personnel involved in handling rejected vials at [Company Name] for the production of intramuscular, subcutaneous, and intravenous injection products.

3) Responsibilities

The responsibilities of this SOP include:
– Production Operators: Identifying and segregating rejected vials.
– Quality Control (QC) Department: Verifying the rejection criteria and conducting necessary tests.
– Quality Assurance (QA) Department: Reviewing and approving handling procedures and records.

See also  SOP for Label Control and Accountability

4) Procedure

4.1 Identification of Rejected Vials
4.1.1 Identify vials that do not meet quality standards during inspection or testing.
4.1.2 Mark the rejected vials clearly with a rejection label.
4.2 Segregation of Rejected Vials
4.2.1 Immediately remove rejected vials from the production line.
4.2.2 Place rejected vials in a designated rejection bin or area to prevent mix-up with acceptable products.
4.3 Documentation of Rejected Vials
4.3.1 Record the batch number, quantity, and reason for rejection in the rejection log.
4.3.2 Ensure the rejection log is signed and dated by the responsible personnel.
4.4 Investigation of Rejected Vials
4.4.1 Conduct an investigation to determine the cause of rejection.
4.4.2 Record the investigation findings and any corrective actions taken.
4.4.3 Implement corrective and preventive actions (CAPA) to prevent recurrence of the issue.
4.5 Disposal of Rejected Vials
4.5.1 Dispose of rejected vials according to the company’s waste disposal procedures.
4.5.2 Ensure that disposal is carried out in compliance with environmental and regulatory guidelines.
4.6 Documentation
4.6.1 Maintain records of all rejected vials, including identification, segregation, investigation, and disposal.
4.6.2 Ensure all records are signed and dated by the responsible personnel.

See also  SOP for Labeling of Vials

5) Abbreviations, if any

– QA: Quality Assurance
– QC: Quality Control
– CAPA: Corrective and Preventive Actions

6) Documents, if any

– Rejection Log
– Investigation Reports
– Disposal Records

7) Reference, if any

– Good Manufacturing Practices (GMP) Guidelines
– International Organization for Standardization (ISO) Standards
– Environmental and Regulatory Guidelines

8) SOP Version

Version 1.0

Injectables Tags:Analytical method validation for injections, Aseptic media fill trials SOP, Bioburden testing for injections, Cleaning validation for injection equipment, Emulsion stability testing for injections, Formulation development for injections, Homogeneity testing for injections, IM injection SOP, Injection filling volume accuracy, Injection stability testing, Intramuscular injection procedure, Intravenous injection guidelines, IV injection SOP, Needle assembly for syringes SOP, Packaging integrity testing for injections, Particle size analysis for injections, Pre-filled syringe stability testing, Product sterility in aseptic processing, Reconstitution testing for injections, SC injection SOP, Subcutaneous injection technique, Syringe filling and capping SOP, Syringe labeling and inspection SOP, Temperature mapping in storage areas, Viscosity testing for injections

Post navigation

Previous Post: In-Process Control: SOP for Visual Inspection of Injectable Products
Next Post: SOP for pH Determination in Semisolids

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version